Darbepoetin alfa Injection 40mcg | Cresp 40 - Dr. Reddy's

Advanced Erythropoiesis-Stimulating Agent (ESA) Therapy

When managing chronic anemia—particularly in patients with chronic kidney disease or those undergoing specific chemotherapies—healthcare providers require a highly reliable and long-acting clinical intervention. The Darbepoetin alfa Injection 40 mcg (commercially recognized as Cresp 40) provides a potent, targeted erythropoiesis-stimulating therapy designed strictly for subcutaneous administration. Manufactured by Dr. Reddy's Laboratories, a globally respected pioneer in advanced biosimilars and pharmaceutical care, this sterile single-use vial ensures the steady clinical performance necessary for sensitive hematological health management.

Why Choose Cresp 40 for Specialized Anemia Management?

Stimulating red blood cell production efficiently requires a medication that provides consistent, potent results with minimal patient burden. Instead of relying on shorter-acting epoetin therapies that require highly frequent administration, clinical specialists benefit from Darbepoetin alfa's modified protein structure. This advanced formulation ensures a prolonged half-life, allowing for extended dosing intervals while maintaining target hemoglobin levels. Dr. Reddy's provides the built-in trust and rigorous biological quality control that nephrologists, oncologists, and specialized pharmacies demand.

Key Product Specifications & Clinical Benefits

Long-Acting Formulation: Contains premium-grade Darbepoetin alfa equivalent to 40 mcg, a highly effective biological agent that stimulates erythropoiesis with a sustained duration of action.

Efficient Single-Use Format: Supplied as a 1 mL single-use vial, providing a precise therapeutic dose while minimizing the risk of cross-contamination during preparation.

Targeted Subcutaneous Delivery: Formulated strictly for subcutaneous use only, allowing for steady systemic absorption and consistent hematological support.

Optimized Patient Compliance: The extended half-life characteristic of Darbepoetin alfa enables less frequent injection schedules compared to traditional recombinant human erythropoietin therapies.

Essential Storage & Usage Guidelines

Maintaining the delicate biological integrity of this ESA medication is absolutely vital for its clinical efficacy.

Refrigeration Required: Store the vial strictly in a refrigerator between 2°C to 8°C (36°F to 46°F).

Do Not Freeze: Freezing will destroy the active protein structure. Protect the medication from intense light at all times. Refer to the enclosed Patient Information Leaflet for exact dosage, administration, and preparation instructions as directed by the prescribing physician.

Important Notice: Cresp 40 is a Prescription Drug. Warning: To be sold by retail on the prescription of a "Registered Medical Practitioner" only. Keep all medicines safely out of the reach of children.